학술논문

Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma
Document Type
Article
Source
In: Blood. (Blood, 28 April 2011, 117(17):4530-4541)
Subject
Language
English
ISSN
15280020
00064971